scy-635
Small moleculeexperimental
Clinical trial activity
2 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Apr 1, 2007 (NCT01290965)
Timeline
Indications
Studied for
Mechanism of action
- Cytochrome P450 3A43INHIBITOR
CYP3A43 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- scy-635
- scy-635
- scy-635
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01265511 | Phase 2 | Nov 1, 2010 | Duke University, Scynexis, Inc. |
| NCT01290965 | Phase 1 | Apr 1, 2007 | Department of Veteran Affairs, Quest Clinical Research, Scynexis, Inc. |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Scynexis, Inc. | For profit | 2 | 2 | 2 | 2007 |
| Department of Veteran Affairs | Government | 1 | 0 | 1 | 2007 |
| Duke University | Academic/Hospital | 1 | 0 | 1 | 2010 |
| Quest Clinical Research | For profit | 1 | 0 | 1 | 2007 |
4 organizations
Page 1 / 1